Xtandi 40 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DB25FG62B
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order from the Defense Logistics Agency (DLA) valued at $4,169.59 for 120 tablets of Xtandi 40 mg. The contract, awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a pharmaceutical supply delivery to support Department of Defense healthcare operations. This delivery order was issued without a set-aside designation, allowing the vendor to compete on a full and open basis.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.99 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities worldwide. Xtandi, an oncology treatment used in prostate cancer therapy, falls within the contract's broad portfolio of branded and generic prescription drugs, biologics, and specialty medications. The vendor's established position as a key supplier in the federal pharmaceutical supply chain and its consistent track record of fulfilling similar delivery orders for the DLA underscore its capability to meet Department of Defense pharmaceutical distribution requirements.
Quick answers
Who was awarded contract SPE2DB25FG62B?
SPE2DB25FG62B was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FG62B worth?
The government has obligated $4,170 on SPE2DB25FG62B.
Is contract SPE2DB25FG62B an order under another contract?
Yes. SPE2DB25FG62B is a delivery order under SPE2DB20D9157, an indefinite delivery contract.
Was contract SPE2DB25FG62B competed?
The extent of competition for SPE2DB25FG62B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award